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We read with great interest the review by Dr Natalya Azadeh and colleagues published in 
Chest on the role of infections in idiopathic ILD (1). Mechanisms enhancing infections in 
chronic respiratory diseases are poorly understood, and wider discussion of new insights into 
potential mechanisms contributing to bacterial and viral infection vulnerability would be 
valuable. A fundamental issue is how these pathogens initially adhere to the airway 
epithelium. We suggest that our recent work on microbial adhesion sites on the airway 
epithelium in COPD, which might aid the understanding of enhanced infectivity in ILD, and 
would be an important area if investigation in this context.  
 
We recently published that platelet-activating factor receptor (PAFr) that is potentially an 
important adhesion site for Streptococcus pneumoniae and non-typeable Haemophilus 
influenzae (NTHI) is highly expressed in the airway epithelium of smokers and especially 
COPD patients and (2, 3). The interaction between these pathogens and the epithelium occurs 
because these bacteria almost uniquely express ChoP (a molecular mimic of PAF) on their 
surface (2). Importantly, we also have found that inhaled corticosteroid tends to increase 
PAFr expression in COPD patients, which might explain why patients on these treatments are 
at higher risk of pneumococcal infections (2). In a follow up study, we also reported high 
PAFr expression in the small airway and alveolar epithelium of COPD patients (4). In an in-
vitro study, we also observed that antagonising PAFr significantly decreased the adherence of 
both pneumococci and NTHI to pulmonary epithelium (3). We also reported recently that the 
intracellular adhesion molecule-1 (ICAM-1), an adhesin for most human rhinoviruses, as well 
as NTHI, is upregulated in COPD airways (5).  
 
Similar to COPD, ILD patients are frequently smokers or ex-smokers, and undergo acute 
exacerbations in which bacterial and/or viral infections are implicated, but there is little 
understanding of mechanisms involved. It is again possible that PAFr and ICAM-1 might be 
up-regulated on respiratory epithelium to provide key adhesion sites, which could explain at 
least some of this increased susceptibility. However, little if any work has been done on these 
microbial adhesins in ILD, inspite of a lot of interest in bacterial/viral colonisation. We feel 
that this deficiency needs to be rectified, as again it could have substantial translational 
therapeutic implications. Thus, lessons we are beginning to be learned in COPD research that 
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